Navigation Links
Gene Therapy shows promise in treating Hemophilia

Researchers at Beth Israel Deaconess Medical Center reported in the current New England Journal of Medicine that an experimental Gene Therapy method has safely introduced new genes into six men suffering from hemophilia. This method shows signs of helping these men fight the disease by producing the blood clotting protein they lack. None of the patients suffers side effects even after one year of the treatment.

The study was designed only to test the safety and not the effectiveness of the treatment of hemophilia. This disease is genetically transmitted and is characterised by excessive bleeding. Researchers belive this study could some day be applied to treat other diseases such as diabetes. For thousands of hemophiliacs around the world, this treatment using gene therapy will come as a life saving blessing.

However the researchers are cautious and feel more examination is necessary before the method can be declared safe. Further studies are on to cross check that the cells inserted as a part of this method into the patients body do not cause the reaction or turn malignant. The next step is to look for ways to produce more clotting factor consistently.
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. "Make AIDS Therapy affordable" - Physicians demand
4. Hormone replacement Therapy a headache
5. Simple Therapy
6. Therapy for stopping the spread of cancer cells
7. Gene Therapy Destroys Pancreatic Cancer Cells
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Garlic Supplements Impede HIV Therapy
10. Gene Therapy For Cystic Fibrosis
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is proud to ... the latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes ... Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrations will ...
(Date:5/5/2016)... ... May 05, 2016 , ... Phycologia – ... (UV-A) for photosynthesis, researchers Juntian Xu and Kunshan Gao tested the magnitude of ... observed that when photosynthetically active radiation (i.e. the white light in our visible ...
(Date:5/5/2016)... ... May 05, 2016 , ... Every year 220 ... heartfelt wishes of these children. The wishes provide hope and motivation through ... CEO of Make-A-Wish Mississippi, Brent Wilson said, “In 2016, the organization will grant ...
(Date:5/5/2016)... ... 05, 2016 , ... Long Island’s fastest growing comprehensive eye care provider, ... surgeon, Kathleen Van Valkenburg, MD as part of their ongoing effort to increase ophthalmic ... and managing partner of North Shore Eye Care. , “We are extremely proud ...
(Date:5/5/2016)... ... ... TIME for Kids and The ZAC Foundation – a national leader in drowning ... million children with important water safety messages before summer break begins. , ... in children one to 6 years of age. TIME for Kids and The ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 Valeritas ... of an alternative public offering (APO). This was accomplished ... company, Valeritas, Inc. and a private placement of approximately ... $5.00 per share. Under the terms of ... 2016, Valeritas Holdings, Inc. will trade on the OTC ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Ischemic ... 2016"  report to their offering.  ... Global Acute Ischemic Stroke Market ... insights into Acute Ischemic Stroke pipeline products, ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
Breaking Medicine Technology: